Physician profile
Harsh Patel
NPI 1710368097
$5,612.19
in general payments reported to CMS, 2019-2025
22 companies · $519 in 2025
The $519 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $207 · 2020: $55.51 · 2021: $743 · 2022: $1,476 · 2023: $2,023 · 2024: $589 · 2025: $519.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,760 · Travel and Lodging: $1,199.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,760.29 |
| Travel and Lodging | $1,198.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,192.36 | 2021-2024 | Corevalve Evolut R, Onyx Frontier, Reveal Linq |
| Philips North America LLC | $892.43 | 2023 | |
| Abbott Laboratories | $791.58 | 2021-2024 | Navitor, Mitraclip, Aveir |
| Shockwave Medical, INC | $175.01 | 2024-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Boston Scientific Corporation | $164.02 | 2023-2025 | Varithena Administration Pack, Watchman Flx |
| Amgen INC. | $157.87 | 2021-2025 | Repatha, Repatha |
| Cvrx, INC. | $106.83 | 2024-2025 | Barostim Neo System |
| E.R. Squibb & Sons, L.L.C. | $97.10 | 2021-2025 | Camzyos |
| Bayer Healthcare Pharmaceuticals INC. | $95.24 | 2025 | |
| Actelion Pharmaceuticals US, INC. | $73.29 | 2024 | Opsumit |
| Novartis Pharmaceuticals Corporation | $66.05 | 2024-2025 | |
| Astrazeneca Pharmaceuticals LP | $58.12 | 2022-2024 | Farxiga |
| Edwards Lifesciences Corporation | $56.60 | 2024 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Inspire Medical Systems, INC. | $30.54 | 2025 | Inspire |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $20.49 | 2025 | Lifevest |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Terumo Medical Corporation | $18.76 | 2023 | Glidewire |
| Bridgebio Pharma, INC. | $18.62 | 2025 | Attruby |
| Boehringer Ingelheim Pharmaceuticals, INC. | $18.56 | 2024 | Jardiance |
| Pfizer INC. | $16.75 | 2024 | |
| Irhythm Technologies, INC. | $14.96 | 2022 | |
| Abiomed | $10.61 | 2024 | |
| Altathera Pharmaceuticals LLC | $9.83 | 2025 | Sotalol Hydrochloride |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Harsh Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.